Table 2 Demography and clinical characteristics of the cohort according to the presence of LVO
LVO present (N = 183) | LVO absent (N = 238) | P value | |
|---|---|---|---|
Age, years, median (IQR) | 67 (60–78) | 69 (58.75–76.25) | 0.652 |
Gender, female, % (n) | 52.5 (96) | 45.8 (109) | 0.175 |
NIHSS score, median (IQR) | 11 (6–16) | 6 (4–9) | < 0.001 |
CPSS score, median (IQR) | 3 (2–3) | 2 (2–3) | < 0.001 |
d-CPSS score, median (IQR) | 5 (3–7) | 3 (2–4.25) | < 0.001 |
Onset to ER assessment time, min, median (IQR) | 80 (58–121.25) | 92 (58.75–137.25) | 0.053 |
On admission SBP, mmHg, mean (SD) | 159.0 (30.3) | 167.8 (29.9) | 0.003 |
On admission DBP, mmHg, mean (SD) | 88.2 (16.0) | 91.2 (17.1) | 0.066 |
Smoking, % (n), 51 missing | 37.0 (57) | 31.5 (68) | 0.267 |
Hypertension, % (n), 15 missing | 79.5 (140) | 79.6 (183) | 0.996 |
Diabetes mellitus, % (n), 19 missing | 19.4 (34) | 26.0 (59) | 0.122 |
Hyperlipidaemia, % (n), 37 missing | 55.7 (93) | 55.3 (120) | 0.939 |
Atrial fibrillation, % (n), 23 missing | 35.8 (62) | 16.9 (38) | < 0.001 |
Coronary artery disease, % (n), 29 missing | 25.9 (45) | 17.4 (38) | 0.042 |
Chronic heart failure, % (n), 25 missing | 14.4 (25) | 8.1 (18) | 0.047 |